Recurrent Implantation Failure (RIF): The Clinical Investigation Checklist

Experiencing multiple failed IVF cycles despite transferring high-quality embryos is an emotionally devastating barrier for couples. Medically, this condition is known as Recurrent Implantation Failure (RIF). When standard protocols do not result in pregnancy, a deep, systematic diagnostic review becomes vital. Prof. (Dr.) Abha Majumdar utilizes a multi-layered investigative checklist to identify hidden maternal and embryonic factors, paving a clear, predictable pathway for subsequent cycle success.

Defining RIF: When Does an IVF Failure Require Investigation?

Clinicians define RIF when a patient fails to achieve a clinical pregnancy after transferring at least three high-grade cleavage-stage embryos or two optimal blastocysts. This failure must occur across multiple fresh or frozen cycles. Consequently, repeating identical treatments without modifying diagnostic parameters rarely yields positive outcomes.

Furthermore, implantation is a complex biochemical dialogue between a competent embryo and a receptive endometrial lining. If either side displays structural or genetic irregularities, the attachment process terminates immediately. Therefore, we break our investigative framework down into distinct biological categories to isolate the root cause effectively.

Professor’s Medical Insight: Do not lose hope after failed transfers. Many patients assume their body is rejecting the baby permanently. In reality, fine-tuning the uterine microenvironment or correcting subtle blood clotting profiles frequently resolves long-standing implantation barriers.

The RIF Diagnostic Investigation Checklist

Our advanced tertiary center at Sir Ganga Ram Hospital addresses RIF through a structured, step-by-step diagnostic strategy:

Therapeutic Interventions for Subsequent Cycles

Once your checklist metrics highlight the primary biological barrier, our medical team alters subsequent treatment protocols:

• Surgical Correction: If hysteroscopy reveals an anatomical variation or localized scarring, performing precise operative resection restores normal uterine architecture instantly.
• Anticoagulant Support: Patients testing positive for clotting variations receive micro-doses of low-molecular-weight heparin (LMWH) alongside low-dose aspirin starting from the embryo transfer day.
• Extended Progesterone Alignment: If your molecular ERA analysis shows a pre-receptive lining, we precisely recalibrate the hours of hormonal priming before attempting a transfer.